Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy
NCT04943094 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-05-31
Summary
The aim is to evaluate and compare treatment strategies for non-muscle invasive bladder cancer. Furthermore, the impact of intravesical instillations on bladder function will be examined by urodynamic examination both prior to and following instillation therapy.
Conditions
Interventions
- OTHER
-
Urodynamic examination
A urodynamic examination is performed in all patients four to six weeks following TURBT and repeated six months later in order to obtain bladder function and possible changes.
Sponsors & Collaborators
-
Aarhus University Hospital
lead OTHER
Principal Investigators
-
Jørgen B. Jensen, DMSc, MD · Aarhus University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-01
- Primary Completion
- 2022-12-31
- Completion
- 2025-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder
NCT03529890 ·Status: UNKNOWN ·Phase: PHASE2
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 ·Status: UNKNOWN
-
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
NCT05223491 ·Status: COMPLETED ·Phase: NA
-
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
NCT02560584 ·Status: COMPLETED ·Phase: PHASE3
-
Adaptive Radiotherapy Using Plan Selection for Bladder Cancer
NCT01762527 ·Status: COMPLETED ·Phase: NA
-
In Vivo Proof-of-principle Study of Raman Spectroscopy in Trial Participants With Bladder Tumours
NCT05124106 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Ultrasound Probe for Use in Bladder Radiotherapy
NCT01698359 ·Status: UNKNOWN
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
Simulation in Transurethral Bladder Cancer Surgery
NCT03864302 ·Status: UNKNOWN ·Phase: NA
-
Patient-reported Outcomes in Bladder Cancer
NCT03584659 ·Status: COMPLETED ·Phase: NA
-
Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment
NCT06679920 ·Status: RECRUITING ·Phase: NA
-
Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer
NCT02381912 ·Status: COMPLETED
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
NCT02547350 ·Status: UNKNOWN ·Phase: PHASE2
-
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
NCT04194112 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
NCT06331299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Drug Screening Using IMD in Bladder Cancer
NCT06204614 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Preoperative Subclinical DVT Screening in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy.
NCT04502498 ·Status: UNKNOWN
-
Radiogenomics of Muscle Invasive Bladder Cancer
NCT04806334 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
NCT06719232 ·Status: RECRUITING
-
A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up
NCT04432909 ·Status: UNKNOWN
-
Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC
NCT03348969 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
NCT04726735 ·Status: COMPLETED
-
A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy
NCT07342517 ·Status: WITHDRAWN ·Phase: PHASE3
-
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
NCT06525571 ·Status: RECRUITING ·Phase: PHASE3